Comparative Study
Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study
- PMID: 1064679
Item in Clipboard
Comparative Study
Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study
J Med.
1976.
Abstract
The uptake of Adriamycin (AM) and Daunomycin (DM) in L1210 leukemia cells was found to be dependent on drug dose, time, and temperature. DM was taken up to a greater extent in human leukemia cells in vitro and in L1210 leukemic cells both in vitro and in vivo. Intracellular retention of DM was less than that of AM. Drug transport appears to be a factor in developing resistance to DM in L1210 cells, but the data for AM were inconclusive in this regard. The importance of cellular uptake and retension operative in determining differences in the overall therapeutic efficacy in vivo remains to be elucidated.
Similar articles
-
Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.Cancer Res. 1983 Jul;43(7):3074-9. Cancer Res. 1983. PMID: 6189591
-
Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.Cancer Res. 1980 Jun;40(6):1928-33. Cancer Res. 1980. PMID: 7371027 No abstract available.
-
Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.Cancer Treat Rep. 1979 May;63(5):861-7. Cancer Treat Rep. 1979. PMID: 455327
-
Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.Cancer Treat Rev. 1987 Dec;14(3-4):319-27. doi: 10.1016/0305-7372(87)90024-7. Cancer Treat Rev. 1987. PMID: 3326668 Review. No abstract available.
-
In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.Immunol Rev. 1982;62:5-27. doi: 10.1111/j.1600-065x.1982.tb00387.x. Immunol Rev. 1982. PMID: 7042540 Review. No abstract available.
Cited by
-
Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.Eur J Clin Pharmacol. 1985;29(1):127-9. doi: 10.1007/BF00547382. Eur J Clin Pharmacol. 1985. PMID: 4054202
-
Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.Cancer Chemother Pharmacol. 1979;2(1):49-52. doi: 10.1007/BF00253105. Cancer Chemother Pharmacol. 1979. PMID: 498420
-
Doxorubicin concentrations in plasma and myocardium and their respective roles in cardiotoxicity.Cardiovasc Drugs Ther. 1988 Jan;1(5):559-60. doi: 10.1007/BF02125741. Cardiovasc Drugs Ther. 1988. PMID: 3154684
-
Uptake of adriamycin by human leukemic cells as measured by flow cytometry.Med Oncol Tumor Pharmacother. 1984;1(1):43-8. doi: 10.1007/BF02935324. Med Oncol Tumor Pharmacother. 1984. PMID: 6544358
-
Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells.Cancer Chemother Pharmacol. 1986;18(2):105-10. doi: 10.1007/BF00262277. Cancer Chemother Pharmacol. 1986. PMID: 3539383